We have learned that Time-Cap Labs, producer of a generic version of the brand name drug Armour, a natural and bioidentical thyroid replacement, has been ordered by the FDA to stop production. The FDA has decided to classify the company’s product, available for over a century, as an unapproved new drug. Since the new drug […]
The Senate’s “Food Safety” bill is better than the House’s in some important respects. For example, it drops the draconian jail sentences and fines for vague infractions including paperwork errors. But it includes a Codex provision that absolutely must be removed by amendment in order to protect free choice about supplements. Please take action to […]
Thank you to our 801 advocates who used AAHF’s Action Center to submit comments in response to Docket Number FDA-200-N-0247, letting the Food and Drug Administration’s Transparency Task Force know that you support increased transparency at the FDA. On August 6, AAHF proudly hand-delivered 801 letters to the FDA’s Division of Docket Management. These comments […]
Nine French lawmakers, citing the ban by Canada and a number of U.S. states, have proposed legislation to ban bisphenol A (BPA) in all food containers (including baby bottles) setting the stage for France to become the first European country to ban BPA. In May, Denmark’s parliament passed a resolution calling on its government to […]
The FDA reclassification moves dental amalgams from low risk (Class I) to moderate risk (Class II). Many dentists have already abandoned dental amalgam fillings, perhaps ringing the death knell for mercury fillings.
A recent issue of Pulse of Health Freedom addressed HR2749, the Food Safety Enhancement Act that was co-sponsored by Congressman Henry Waxman. AAHF legislative director Tami Wahl has continued her work on the bill by publicizing our full-page ad in Roll Call; meeting with Congressman Peter Welch (D–VT) and contacting Congressman Collin Peterson (D–MN), chair […]
Americans are demanding to know how the US Food and Drug Administration makes its decisions about the medicine they take and the food they consume.
Bayer Healthcare could face a lawsuit in the US over its claim that selenium may reduce the risk of prostate cancer. Bayer makes that claim on advertisements and labels for its One A Day Men’s multivitamin.
Pharmaceutical companies have figured out that the FDA can be reshaped into a tool to increase their profits instead of doing its actual job—screening drugs for safety on behalf of consumers. First, there was the pharmaceutical company assault on your access to vitamin B6. The FDA has now ended your access to one of the […]
The FDA has established a Transparency Task Force, and has called for public comment. We certainly applaud this as a hopeful sign. Openness in government is imperative, and prompt disclosure to the public of government activity ensures legitimacy and accountability.